Beatrix Lutiger

Author PubWeight™ 15.49^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.	Lancet	2003	9.80
2	The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).	Cardiovasc Drugs Ther	2004	1.70
3	Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.	Eur Heart J	2005	1.12
4	Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).	Eur J Heart Fail	2004	0.92
5	Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.	Am Heart J	2005	0.85
6	Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).	Eur J Heart Fail	2005	0.79
7	Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?	Future Oncol	2014	0.78